Analysis
Agilent Technologies' LC/MS Manufacturing Achieves ISO 13485 Certification
Agilent Technologies Inc., have announced that its liquid chromatography/mass spectrometry systems, including 6100 Series single quadrupole and 6400 Series triple quadrupole systems, are now manufactured under ISO 13485 certification. This is an internationally recognized standard of quality management for the design and manufacture of medical devices.
ThisThese systems are well-proven in toxicology, clinical research, metabolomics, proteomics and chemical analysis, added John Fjeldsted, Agilent general manager, LC/MS. There's value in having the additional validation of an ISO 13485-registered quality management system on top of our own high standards of quality design and manufacturing as we pursue approval for the clinic.
In March 2010, Agilent achieved ISO 13485 certification for the design and manufacture of its entire portfolio of DNA microarrays and microarray scanner platform. In June 2011, Agilent announced that its Cedar Creek, Texas, reagent manufacturing facility has been registered with the U.S. Food and Drug Administration as a medical device establishment. This registration is required for the manufacture of diagnostic products.